Listeria monocytogenes infection associated with alemtuzumab – - a case for better preventive strategies

Listeria monocytogenes infection associated with alemtuzumab – - a case for better preventive strategies

Abstract Background The mortality of septicaemia, meningitis and encephalitis caused by Listeria monocytogenes is 20–40%. Twenty-one cases of invasive listeriosis associated with alemtuzumab, including at least 16 in patients with multiple sclerosis, have been published or reported to the World Heal...

Full description

Bibliographic Details
Main Authors: Trygve Holmøy, Hedda von der Lippe, Truls Michael Leegaard
Format: Article
Language:English
Published: BMC 2017-04-01
Series:BMC Neurology
Subjects:
Multiple sclerosis
Treatment
Alemtuzumab
Adverse events
Listeria monocytogenes
Online Access:http://link.springer.com/article/10.1186/s12883-017-0848-8

Internet

http://link.springer.com/article/10.1186/s12883-017-0848-8

Similar Items